CLSL — Crop Life Science Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹942.70m
- IN₹1.41bn
- IN₹2.01bn
- 59
- 74
- 75
- 83
Annual cashflow statement for Crop Life Science, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 49.3 | 37.7 | 56 | 56 | 78 |
| Depreciation | |||||
| Non-Cash Items | 16.5 | 22.6 | 24.9 | 34.7 | 42.7 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -55.9 | -84.2 | -95.2 | -218 | -190 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 35 | -1.45 | 22.7 | -83.3 | -21 |
| Capital Expenditures | -26.3 | -43.7 | -50.2 | -74.4 | -39 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 4.87 | 23.8 | 5.32 | 40.2 | 3.98 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -21.5 | -19.9 | -44.8 | -34.2 | -35 |
| Financing Cash Flow Items | -18.7 | -20.7 | -32.7 | -43.4 | -47.5 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -5.74 | 11.1 | 5.2 | 134 | 41.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 7.8 | -10.2 | -16.9 | 16.7 | -14.4 |